Hsbc Holdings PLC Has $517,000 Stock Position in Viemed Healthcare, Inc. $VMD

Posted by Brenda Bartman on Aug 1st, 2026

Hsbc Holdings PLC lowered its stake in Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) by 46.0% during the first quarter, HoldingsChannel reports. The firm owned 55,883 shares of the company’s stock after selling 47,686 shares during the period. Hsbc Holdings PLC’s holdings in Viemed Healthcare were worth $517,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the stock. North Star Investment Management Corp. acquired a new position in shares of Viemed Healthcare in the first quarter worth about $921,000. Expect Equity LLC increased its position in shares of Viemed Healthcare by 59.6% in the fourth quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after acquiring an additional 64,961 shares in the last quarter. Quarry LP acquired a new stake in shares of Viemed Healthcare during the third quarter valued at approximately $48,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Viemed Healthcare during the fourth quarter valued at approximately $46,000. Finally, Diversified Trust Co purchased a new stake in shares of Viemed Healthcare in the 1st quarter valued at approximately $107,000. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Viemed Healthcare in a research note on Friday, July 17th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, Viemed Healthcare currently has an average rating of “Hold”.

Get Our Latest Analysis on Viemed Healthcare

Insider Transactions at Viemed Healthcare

In other news, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the completion of the sale, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider William Frazier sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the sale, the insider owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 20.60% of the stock is owned by corporate insiders.

Viemed Healthcare Stock Down 0.8%

NASDAQ:VMD opened at $11.67 on Friday. The firm has a market capitalization of $447.43 million, a price-to-earnings ratio of 31.54 and a beta of 1.10. Viemed Healthcare, Inc. has a 1-year low of $5.93 and a 1-year high of $12.61. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. The business’s fifty day moving average price is $11.12 and its 200 day moving average price is $9.65.

Viemed Healthcare (NASDAQ:VMD – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The business had revenue of $75.41 million during the quarter, compared to analysts’ expectations of $74.40 million. On average, sell-side analysts forecast that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Viemed Healthcare Company Profile

(Free Report)

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.